IANNETTA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.624
AS - Asia 4.135
EU - Europa 2.522
SA - Sud America 642
AF - Africa 91
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.046
Nazione #
US - Stati Uniti d'America 5.479
SG - Singapore 1.985
IT - Italia 854
CN - Cina 623
BR - Brasile 529
HK - Hong Kong 490
RU - Federazione Russa 436
VN - Vietnam 347
IE - Irlanda 289
BD - Bangladesh 211
DE - Germania 196
FR - Francia 144
JP - Giappone 127
GB - Regno Unito 123
SE - Svezia 99
CA - Canada 85
FI - Finlandia 85
IN - India 81
NL - Olanda 80
ID - Indonesia 50
AT - Austria 49
AR - Argentina 44
TR - Turchia 43
PL - Polonia 41
MX - Messico 38
IQ - Iraq 33
ES - Italia 32
ZA - Sudafrica 28
KR - Corea 26
AU - Australia 24
PK - Pakistan 19
EC - Ecuador 18
CO - Colombia 15
IR - Iran 14
PH - Filippine 12
BE - Belgio 10
CL - Cile 10
CZ - Repubblica Ceca 10
EG - Egitto 10
KE - Kenya 10
LT - Lituania 10
MA - Marocco 10
UA - Ucraina 10
VE - Venezuela 10
CH - Svizzera 9
PY - Paraguay 9
JO - Giordania 8
SA - Arabia Saudita 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
MY - Malesia 7
GR - Grecia 6
NG - Nigeria 6
UZ - Uzbekistan 6
JM - Giamaica 5
KG - Kirghizistan 5
PE - Perù 5
RO - Romania 5
AZ - Azerbaigian 4
DK - Danimarca 4
EU - Europa 4
GH - Ghana 4
HU - Ungheria 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
SC - Seychelles 3
TH - Thailandia 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GA - Gabon 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
Totale 13.034
Città #
Singapore 1.034
San Jose 590
Hong Kong 481
Ashburn 423
Fairfield 357
Wilmington 293
Rome 275
Chandler 261
Beijing 260
Houston 222
Dublin 218
Council Bluffs 205
New York 184
Los Angeles 156
Santa Clara 156
Medford 150
The Dalles 138
Woodbridge 136
Tokyo 126
Ho Chi Minh City 124
Cambridge 118
Seattle 118
Buffalo 84
Ann Arbor 80
Hanoi 69
Lawrence 69
Lauterbourg 65
Moscow 62
Milan 59
Helsinki 55
Nuremberg 54
Dallas 52
Chicago 47
Munich 47
San Diego 47
Frankfurt am Main 42
São Paulo 40
Toronto 34
Orem 33
North Bergen 32
London 30
Jakarta 29
Lappeenranta 26
Seoul 25
Naples 22
Rio de Janeiro 22
Warsaw 22
Chennai 21
Curitiba 21
Menlo Park 21
Montreal 21
Brooklyn 20
Da Nang 20
Amsterdam 17
Atlanta 17
Denver 17
Engelhard 17
Stockholm 17
Mexico City 16
Boardman 15
Phoenix 15
Vienna 15
Ankara 14
Colorado Springs 14
Haiphong 13
Johannesburg 13
San Francisco 13
Bologna 12
Falls Church 12
Istanbul 12
Manchester 12
Palo Alto 12
Salt Lake City 12
Tampa 12
Adelaide 11
Kilburn 11
Miami 11
Belo Horizonte 10
Brussels 10
Elk Grove Village 10
Guangzhou 10
Paris 10
Redondo Beach 10
Boston 9
Mumbai 9
Sydney 9
Umuarama 9
Biên Hòa 8
Chandigarh 8
Quito 8
Wuhan 8
Amman 7
Brno 7
City of London 7
Creede 7
Dearborn 7
Hải Dương 7
Madrid 7
Manila 7
Nairobi 7
Totale 7.817
Nome #
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 396
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis 298
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 207
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 185
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 179
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 178
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study 162
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 161
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 159
P-375. Long-Term Suppressive Antimicrobial Therapy in Prosthetic Vascular Graft Infection: a Five-Year Retrospective Evaluation 158
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 155
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 152
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 151
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 140
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 138
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 136
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 133
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 132
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 127
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 124
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 121
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 120
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 119
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 119
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 118
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 114
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae 113
Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 111
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 110
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 110
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment 109
Blood myeloid dendritic cells and slanDC in antiretroviral therapy-Suppressed HIV-infected patients 108
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 107
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection 105
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 104
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 104
Archetype and rearranged non-coding control regions in urothelial bladder carcinoma of immunocompetent individuals 103
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 103
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 102
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 101
Natalizumab affects T-Cell phenotype in multiple sclerosis: Implications for JCV reactivation 101
ZIKV infection induces an inflammatory response but fails to activate types I, II, and III IFN response in human PBMC 101
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells 101
Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis 100
Histoplasmosis in patients living with HIV in Europe: review of literature 100
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study 99
Altered antigen-presenting cells during HIV-1 infection 99
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 99
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review 98
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus 96
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 95
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 95
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 95
Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis 95
In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response 95
Cell-associated {HIV} cross-presentation by plasmacytoid dendritic cells is potentiated by noncognate {CD}8$mathplus$ T cell preactivation 95
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 95
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 93
Hiv-2 infection in a migrant from gambia: The history of the disease combined with phylogenetic analysis revealed the real source of infection 93
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 92
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 (vol 25, pg 5889, 2021) 91
Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man 91
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factors 91
Viral Hemorrhagic Fevers Other than Ebola and Lassa 89
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 88
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 88
Case report: Delayed diagnosis of congenital malaria by plasmodium vivax in a newborn of an Eritrean woman with varicella infection 88
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19 87
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 87
HIV-associated progressive multifocal leukoencephalopathy: Longitudinal study of JC virus non-coding control region rearrangements and host immunity 87
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 86
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 86
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients 85
In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection 85
Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report 85
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. 85
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 84
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections 84
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 81
HIV-associated progressive multifocal leukoencephalopathy: Current perspectives 81
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin 80
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 79
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 79
JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis 79
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection 79
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 78
NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients 78
Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device 78
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 76
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 76
Sustained Remission in Relapsed/Refractory Diffuse Large B Cell Lymphoma Following Glofitamab Discontinuation Due to JC Virus Reactivation: Balancing Efficacy and Infectious Risk 75
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 75
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 75
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 75
Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, january 2018 75
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia 75
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era 74
Diagnostic value of JC polyomavirus viruria, viremia, serostatus and microRNA expression in multiple sclerosis patients undergoing immunosuppressive treatment 74
null 74
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 72
Totale 10.864
Categoria #
all - tutte 68.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022974 90 120 55 128 8 77 58 70 63 58 33 214
2022/2023845 84 44 51 62 75 214 92 64 65 12 42 40
2023/2024643 64 22 58 88 43 102 29 44 14 71 23 85
2024/20253.253 72 571 396 193 55 183 334 167 308 431 251 292
2025/20266.537 650 257 607 526 520 261 792 723 806 516 481 398
Totale 13.638